Moreover, Zhao et al. demonstrated that transgenic mice with adipocyte-specific Blnc1 inactivation exacerbated HFD-induced insulin resistance and hepatic steatosis, while body weight gain was not significantly different between control and knockout mice [43]. Here, PAQR9 is linked to fatty liver disease.